Skip to Content



Definition: An analogue of thalidomide with antiangiogenic and immunomodulatory activity used as an antineoplastic agent in multiple myeloma.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.